# AMMF - THE CHOLANGIOCARCINOMA CHARITY

## Details

- **Country:** England &amp; Wales
- **Charity number:** 1198095
- **Status:** Registered
- **Legal form:** CIO
- **Registered:** March 1, 2022
- **Register:** https://register-of-charities.charitycommission.gov.uk/en/charity-search/?p_p_id=uk_gov_ccew_onereg_charitydetails_web_portlet_CharityDetailsPortlet&amp;p_p_lifecycle=0&amp;p_p_state=maximized&amp;p_p_mode=view&amp;_uk_gov_ccew_onereg_charitydetails_web_portlet_CharityDetailsPortlet_regId=1198095


## Contact

- **Address:** Enterprise House, Bassingbourn Road, Stansted, Essex
- **Postcode:** CM24 1QW
- **Phone:** 01279 661479
- **Email:** info@ammf.org.uk
- **Website:** https://ammf.org.uk/



## Activities

**Objects:** THE OBJECTS OF THE CIO ARE, FOR THE PUBLIC BENEFIT, THE ADVANCEMENT OF HEALTH, INCLUDING BY RAISING THE AWARENESS AND UNDERSTANDING OF CHOLANGIOCARCINOMA (BILE DUCT CANCER) AND RELATED CANCERS AND CONDITIONS INCLUDING THROUGH THE PROMOTION OF RESEARCH INTO CAUSES, TREATMENTS AND CURES; AND DISSEMINATION OF INFORMATION TO PATIENTS, CARERS AND HEALTH CARE PROFESSIONALS

**Activities:** AMMF operates across the UK:1. Funding research into methods of earlier diagnosis, effective treatments, causes &amp; cures for CCA2. Providing support to those diagnosed with CCA and their loved ones, through a website, dissemination of information, and patient support 3. Raising awareness regarding CCA via the annual AMMF CCA Conference, and participating with other organisations &amp; initiatives




## Classification

- **How:** Makes Grants To Organisations, Provides Advocacy/advice/information, Sponsors Or Undertakes Research, Acts As An Umbrella Or Resource Body
- **What:** The Advancement Of Health Or Saving Of Lives
- **Who:** The General Public/mankind



## Geography

- Northern Ireland
- Scotland
- Throughout England And Wales





## Trustees

| Name | Role | Appointed |
|---|---|---|
| **Noel Corrigan FORS** | Chair | March 1, 2022 |
| Gillian Corrigan RN |  | March 1, 2022 |
| Harold Corrigan |  | March 1, 2022 |
| TOM MOREMENT |  | March 1, 2022 |




